ACAD stock

ACADIA Pharmaceuticals Inc (ACAD) institutional holders · P/E 8.8, rev $1.07B

ACADIA Pharmaceuticals Inc 13F cache, top 3 holders by reported value. Each row is the filer's newest cached 13F for quarters ended 2026-06-30 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Filers whose newest cached 13F is older are omitted.

Cached 13F holders
HolderSharesValueReport
STATE STREET CORP9,076,212$229.6M2026-06-30
FMR LLC240,384$6.1M2026-06-30
Bridgewater Associates, LP50,265$1.3M2026-06-30
These 13F holders as JSON? API free 100/day

ACAD institutional holders FAQ

How many ACAD 13F holders are listed on this page?

This page lists 3 cached ACADIA Pharmaceuticals Inc (ACAD) 13F holders. Holders: https://lician.com/institutional/acad

Who is the largest ACAD 13F holder by reported value?

The largest cached 13F holder by reported value on this page is STATE STREET CORP. Filer: https://lician.com/institutional/acad/93751. Holders: https://lician.com/institutional/acad

What value and shares did the largest ACAD 13F holder report?

STATE STREET CORP, the largest cached 13F holder by reported value on this page, reported 9,076,212 shares and a value of $229.6M.

What is the latest ACAD 13F report date on this page?

The latest cached 13F report date on this ACADIA Pharmaceuticals Inc (ACAD) holders table is Jun 30, 2026.

Which ACAD 13F holders report the largest positions?

The largest cached 13F holders by reported value on this ACADIA Pharmaceuticals Inc (ACAD) page are STATE STREET CORP, FMR LLC, and Bridgewater Associates, LP. Holders: https://lician.com/institutional/acad

Where are ACAD institutional holders listed?

Cached 13F holders for ACADIA Pharmaceuticals Inc (ACAD) are listed at https://lician.com/institutional/acad. Filer directory: https://lician.com/holders

What is ACAD's P/E ratio?

ACADIA Pharmaceuticals Inc (ACAD) trailing P/E is 8.85 on the latest cached fundamentals snapshot.

What is ACAD's latest revenue?

Latest cached ACADIA Pharmaceuticals Inc (ACAD) revenue for Dec 31, 2025 was $1.07B. Statements: https://lician.com/financials/acad

Not investment advice. Cached rows, not a live tape.